1.

The revised international prognostic scoring system "molecular" (ipss-rm), a validated and dynamic model in treated patients with myelodysplastic syndromes (mds)

Answer»

Answer:

The Revised International Prognostic Scoring System (IPSS-R) was developed to RISK stratify untreated patients (pts) with myelodysplastic syndromes (MDS). ... Recently, GENOME sequencing TECHNOLOGIES have identified recurrent somatic mutations that IMPACT SURVIVAL in MDS



Discussion

No Comment Found